Ajanta Pharma Limited (AJANTPHARM) Financial Statements

5 Followers

Ajanta Pharma Limited Financial Overview

Ajanta Pharma Limited's market cap is currently ₹398.61B. The company's EPS TTM is ₹77.91; its P/E ratio is 33.18; and it has a dividend yield of 1.04%. Ajanta Pharma Limited is scheduled to report earnings on May 5, 2026, and the estimated EPS forecast is ₹25.10. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 54.53B	₹ 45.88B	₹ 41.62B	₹ 37.08B	₹ 32.84B
Gross Profit	₹ 28.05B	₹ 34.60B	₹ 30.46B	₹ 25.91B	₹ 23.97B
Operating Income	₹ 13.25B	₹ 11.28B	₹ 10.46B	₹ 6.80B	₹ 8.12B
EBITDA	₹ 14.98B	₹ 13.54B	₹ 12.57B	₹ 8.81B	₹ 10.44B
Net Income	₹ 10.56B	₹ 9.20B	₹ 8.16B	₹ 5.88B	₹ 7.13B
Balance Sheet
Cash & Short-Term Investments	₹ 6.65B	₹ 6.15B	₹ 4.60B	₹ 8.44B	₹ 3.28B
Total Assets	₹ 61.55B	₹ 50.15B	₹ 46.38B	₹ 46.79B	₹ 40.56B
Total Debt	₹ 2.60B	₹ 474.20M	₹ 352.80M	₹ 356.30M	₹ 250.30M
Net Debt	₹ 1.55B	₹ -1.29B	₹ -942.10M	₹ -2.94B	₹ -1.81B
Total Liabilities	₹ 16.28B	₹ 12.25B	₹ 10.71B	₹ 12.91B	₹ 7.91B
Stockholders' Equity	₹ 45.27B	₹ 37.90B	₹ 35.67B	₹ 33.88B	₹ 32.64B
Cash Flow
Free Cash Flow	₹ 1.51B	₹ 8.39B	₹ 6.33B	₹ 6.17B	₹ 4.13B
Operating Cash Flow	₹ 5.16B	₹ 11.57B	₹ 7.85B	₹ 7.92B	₹ 5.62B
Investing Cash Flow	₹ -4.29B	₹ -3.77B	₹ 653.90M	₹ -5.60B	₹ -741.00M
Financing Cash Flow	₹ -1.55B	₹ -7.33B	₹ -10.51B	₹ -1.08B	₹ -4.60B

Currency in INR

Ajanta Pharma Limited Earnings and Revenue History

Income Statement >

Ajanta Pharma Limited Debt to Assets

Balance Sheet >

Ajanta Pharma Limited Cash Flow

Cash Flow >

Ajanta Pharma Limited Forecast EPS vs Actual EPS

Earnings >